 RESEARCH TRIANGLE PARK, N.C., May 18, 2022 GLOBE NEWSWIRE -- G1 Therapeutics, Inc. Nasdaq: GTHX, a commercial-stage oncology company, today announced that Jack Bailey, G1s Chief Executive Officer, will provide a virtual corporate presentation during the H.C. Wainwright Co. Global Investment Conference. The presentation will become available at 7:00 AM EDT on May 24, 2022. This meeting is being held in person and virtually; the webcast of G1s presentation will be accessible on the Events Presentations page of 